User menu

High serum galectin-3 in advanced melanoma: preliminary results

Bibliographic reference Vereecken, P ; Boudjeltia, KZ ; Debray, C ; Awada, A. ; Legssyer, I ; et. al. High serum galectin-3 in advanced melanoma: preliminary results.Meeting on Perspectives in Melanoma VIII (Berlin(Germany), Sep 24-25, 2004). In: Clinical and Experimental Dermatology, Vol. 31, no. 1, p. 105-109 (2006)
Permanent URL http://hdl.handle.net/2078.1/61131
  1. Barondes Samuel H., Castronovo Vincent, Cooper Douglas N.W., Cummings Richard D., Drickamer Kurt, Felzi Ten, Gitt Michael A., Hirabayashi Jun, Hughes Colin, Kasai Ken-ichi, Leffler Hakon, Liu Fu-Tong, Lotan Reuben, Mercurio Arthur M., Monsigny Michel, Pillai Shiv, Poirer Françoise, Raz Avraham, Rigby Peter W.J., Rini James M., Wang John L., Galectins: A family of animal β-galactoside-binding lectins, 10.1016/0092-8674(94)90498-7
  2. Loris R, Principles of structures of animal and plant lectins, 10.1016/s0304-4165(02)00309-4
  3. Ochieng J, Modulation of the biological functions of galectin-3 by matrix metalloproteinases, 10.1016/s0304-4165(97)00086-x
  4. Hughes R, Secretion of the galectin family of mammalian carbohydrate-binding proteins, 10.1016/s0304-4165(99)00177-4
  5. Yang R.-Y., Liu F.-T., Galectins in cell growth and apoptosis, 10.1007/s000180300022
  6. Barondes SH, J Biol Chem, 269, 20807 (1994)
  7. Debray Charles, Vereecken Pierre, Belot Nathalie, Teillard Peggy, Brion Jean-Pierre, Pandolfo Massimo, Pochet Roland, Multifaceted role of galectin-3 on human glioblastoma cell motility, 10.1016/j.bbrc.2004.10.181
  8. Takenaka Yukinori, Fukumori Tomoharu, Raz Avraham, Galectin-3 and metastasis, 10.1023/b:glyc.0000014084.01324.15
  9. Sulaimon Shola S., Kitchell Barbara E., The Basic Biology of Malignant Melanoma: Molecular Mechanisms of Disease Progression and Comparative Aspects, 10.1892/0891-6640(2003)017<0760:tbbomm>2.3.co;2
  10. Alonso Soledad R., Ortiz Pablo, Pollán Marina, Pérez-Gómez Beatriz, Sánchez Lydia, Acuña Ma Jesús, Pajares Raquel, Martínez-Tello Francisco J., Hortelano Carlos M., Piris Miguel A., Rodríguez-Peralto José L., Progression in Cutaneous Malignant Melanoma Is Associated with Distinct Expression Profiles, 10.1016/s0002-9440(10)63110-0
  11. Balch CM, J Clin Oncol, 19, 3622 (2001)
  12. Buer J, Probst M, Franzke A, Duensing S, Haindl J, Volkenandt M, Wittke F, Hoffmann R, Ganser A, Atzpodien J, Elevated serum levels of S100 and survival in metastatic malignant melanoma, 10.1038/bjc.1997.232
  13. Brochez L., Naeyaert J-M., Serological markers for melanoma, 10.1046/j.1365-2133.2000.03649.x
  14. Deichmann M, Br J Cancer, 91, 699 (2004)
  15. Hoon DSB, Cancer Res, 60, 2253 (2000)
  16. Rubinstein N., Ilarregui J.M., Toscano M.A., Rabinovich G.A., The role of galectins in the initiation, amplification and resolution of the inflammatory response, 10.1111/j.0001-2815.2004.00278.x
  17. Almkvist Jenny, Karlsson Anna, Galectins as inflammatory mediators, 10.1023/b:glyc.0000014088.21242.e0
  18. Rabinovich Gabriel A, Baum Linda G, Tinari Nicola, Paganelli Roberto, Natoli Clara, Liu Fu-Tong, Iacobelli Stefano, Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?, 10.1016/s1471-4906(02)02232-9
  19. Mey Anne, Berthier-Vergnes Ode, Apoil Pol-André, Doré Jean-François, Revillard Jean-Pierre, Expression of the galactose binding protein Mac-2 by human melanoma cell-lines, 10.1016/0304-3835(94)90197-x
  20. Iurisci I, Clin Cancer Res, 6, 1389 (2000)
  21. Califice S, Int J Oncol, 25, 983 (2004)
  22. Akahani Shiro, Inohara Hidenori, Nangia-Makker Pratima, Raz Avraham, Galectin-3 in Tumor Metastasis., 10.4052/tigg.9.69
  23. Perillo N. L., Marcus Madeline E., Baum Linda G., Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death, 10.1007/s001090050232
  24. Rubinstein Natalia, Alvarez Mariano, Zwirner Norberto W, Toscano Marta A, Ilarregui Juan M, Bravo Alicia, Mordoh José, Fainboim Leonardo, Podhajcer Osvaldo L, Rabinovich Gabriel A, Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection, 10.1016/s1535-6108(04)00024-8